The decline of BCR-ABL/GUS ratio in CML patients treated upfront with nilotinib shows a rapid descent during the first trimester, and the responses are similar to those achieved with ABL as control

dc.contributor.author	Sastre Moral, José Luis
dc.date.accessioned	2017-06-07T06:57:49Z
dc.date.available	2017-06-07T06:57:49Z
dc.date.issued	2014
dc.identifier.issn	0390-6078
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1081
dc.language.iso	eng
dc.title	The decline of BCR-ABL/GUS ratio in CML patients treated upfront with nilotinib shows a rapid descent during the first trimester, and the responses are similar to those achieved with ABL as control
dc.type	Publicación de congreso
dc.authorsophos	Casado Montero, L. F.
dc.authorsophos	Gomez-Casares, M. T.
dc.authorsophos	Colomer, D.
dc.authorsophos	Rozman, M.
dc.authorsophos	Echeveste, M. A.
dc.authorsophos	Garcia-Gutierrez, V.
dc.authorsophos	Sastre, J. L.
dc.authorsophos	Ramirez Payer, A.
dc.authorsophos	Olavarria, E.
dc.authorsophos	Val, F.
dc.authorsophos	Xicoy, B.
dc.authorsophos	Giraldo, P.
dc.authorsophos	Conde, E.
dc.authorsophos	Omar Vallansot, R.
dc.authorsophos	Lorenzo, J. L.
dc.authorsophos	Palomera, L.
dc.authorsophos	Ruiz, S.
dc.authorsophos	Walasek, C.
dc.authorsophos	Casas, L.
dc.authorsophos	Steegmann, J. L.
dc.identifier.isi	:000342830900183
dc.identifier.sophos	16958
dc.issue.number	S 1
dc.journal.title	Haematologica
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ourense - Complexo Hospitalario Universitario de Ourense::Hematoloxía clínica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	99

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.